Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age9-15
SponsorUniversity of Calgary
About this trial
Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. Here, we will test if theta burst repetitive transcranial magnetic stimulation (rTMS) can reduce the symptoms of ADHD.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of ADHD
9-15 years old
IQ greater than 80
English fluency (to enable consent/assent)
Disqualifiers
Diagnosis of mania, psychosis, or bipolar disorder
Impediments to TMS or MRI (i.e. metal implants in body)
Prior electroconvulsive therapy or vagus nerve stimulation
Diagnosis of Autism Spectrum Disorder.
Trial design
Design model
Single group
Treatments tested in this trial
rTMS
DeviceRepetitive transcranial magnetic stimulation (rTMS)
Treatment groups
30 Participants
are divided into 1 treatment groupGroup A: Active rTMSExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
TEACH-2
Test of everyday attention in children - 2. Direct assessment of attention abilities in children.
Time frame
Baseline to week 5Secondary outcomes
1
SNAP-18
Parent reporting of ADHD symptom severity
Time frame
5 weeks and 52 weeks.2
PedsQL
Self reporting of quality of life
Time frame
Baseline to week 5Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov